Allarity Therapeutics, Inc. 8-K

What Happened

• Allarity Therapeutics (ALLR) filed an 8-K reporting an Amended and Restated Management Services Agreement (A&R MSA) with Ljungaskog Consulting AB, the consulting firm owned by CEO Thomas H. Jensen, effective June 1, 2026. The A&R MSA replaces the prior agreement dated June 1, 2024 and updates compensation and termination terms.

Key Details

• Compensation: For 2026 the Consultant’s annual base pay will be 80% in Swedish krona and 20% in U.S. dollars — SEK 6,000,000 and US$163,043. The one-time $100,000 signing bonus in the original agreement was removed.
• Bonus: Annual bonus metrics will be issued (or default to prior year’s metrics if not issued by March 31). Annual bonus is capped at 60% of Monthly Fees and, if earned, payable by March 15 following the calendar year.
• Termination by Company: Company notice for convenience increased from 15 to 30 days. If the Company terminates for convenience, the Consultant is entitled to accrued payments plus a Termination Payment equal to 12 months of the Monthly Fee, paid semi-monthly, subject to release, cooperation and surviving obligations.
• Other changes: If the Consultant terminates for Good Reason, the Consultant is now entitled to accrued payments plus the 12‑month Termination Payment (previously nine months). The A&R MSA adds provisions addressing U.S. tax rules (Sections 409A and 280G) if the Consultant is subject to U.S. federal taxation. The full agreement is filed as Exhibit 10.1.

Why It Matters

• These changes increase potential cash obligations to the CEO/consultant on termination (notably a 12-month termination payment) and extend the Company’s notice period, which could affect near-term cash planning and executive compensation expectations. The revised bonus cap and currency split of base pay clarify payout structure for 2026. Investors should note the contract terms when assessing governance, executive costs, and potential future cash outflows.